1. Home
  2. WLDS vs LGVN Comparison

WLDS vs LGVN Comparison

Compare WLDS & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wearable Devices Ltd.

WLDS

Wearable Devices Ltd.

HOLD

Current Price

$1.43

Market Cap

10.9M

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$0.97

Market Cap

11.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDS
LGVN
Founded
2014
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
11.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
WLDS
LGVN
Price
$1.43
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.50
AVG Volume (30 Days)
131.3K
8.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$709,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.48
52 Week High
$11.40
$1.92

Technical Indicators

Market Signals
Indicator
WLDS
LGVN
Relative Strength Index (RSI) 63.68 67.60
Support Level $1.42 $0.55
Resistance Level $1.70 $1.44
Average True Range (ATR) 0.11 0.12
MACD 0.10 0.05
Stochastic Oscillator 64.19 65.60

Price Performance

Historical Comparison
WLDS
LGVN

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: